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Recovery of lower-limb function after spinal cord injury (SCI) is dependent on the
extent of remaining neural transmission in the corticospinal pathway. The aim of this
proof-of-concept pilot study was to explore the effects of long-term paired associative
stimulation (PAS) on leg muscle strength and walking in people with SCI. Five
individuals with traumatic incomplete chronic tetraplegia (>34 months post-injury, motor
incomplete, 3 females, mean age 60 years) with no contraindications to transcranial
magnetic stimulation (TMS) received PAS to one or both legs for 2 months (28 sessions in
total, 5 times a week for the first 2 weeks and 3 times a week thereafter). The participants
were evaluated with the Manual Muscle Test (MMT), AIS motor and sensory examination,
Modified Asworth Scale (MAS), and the Spinal Cord Independence Measure (SCIM) prior
to the intervention, after 1 and 2months of PAS, and after a 1-month follow-up. The study
was registered at clinicaltrials.gov (NCT03459885). During the intervention, MMT scores
and AIS motor scores increased significantly (p = 0.014 and p = 0.033, respectively).
Improvements were stable in follow-up. AIS sensory scores, MAS, and SCIM were not
modified significantly. MMT score prior to intervention was a good predictor of changes
in walking speed (R2adj = 0.962). The results of this proof-of-concept pilot study justify a
larger trial on the effect of long-term PAS on leg muscle strength and walking in people
with chronic incomplete SCI.
Keywords: paired associative stimulation, walking, TMS, spinal cord injury, neuroplasticity
INTRODUCTION
Improving mobility in individuals with chronic spinal cord injury (SCI) remains a major clinical
challenge (1, 2). Recovery of walking after SCI varies considerably and depends on e.g., age
and severity of injury (3). People with incomplete lesions have the greatest probability to regain
movement in the lower limbs as they have residual synaptic connectivity in the corticospinal tracts.
It is known that spontaneous recovery is limited in all SCI subpopulations and usually occurs
during the first 3 months and reaches a plateau by 9 months post-injury (4).
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It is important to develop non-invasive neuromodulation
for restoration of locomotor function (1, 3, 5, 6). Paired
associative stimulation (PAS) specifically targets residual
synaptic connections and may be effective in enhancing
motor control over selected weak muscles. PAS combines
transcranial magnetic stimulation (TMS) of the motor cortex
and peripheral nerve stimulation (PNS) (7, 8). One PAS
consists of a TMS pulse delivered to the cortical target
at a predefined timing interval with the PNS given to a
corresponding contralateral nerve. Repeated TMS-PNS pairing
can induce durable changes in the cortico-cortical (7) and
the corticospinal-motoneuronal synapses, (9) referred to as
long-term potentiation (LTP)-like plasticity (10, 11). The
potential of PAS to increase synaptic strength at the spinal
level has a clear theoretical therapeutic significance for SCI
and provides a possibility for returning motor control over
paralyzed muscles.
Long-term application of PAS with the development of
novel stimulation protocols has shown promising results
in rehabilitation after SCI (12–15). This protocol reinforces
corticospinal transmission at a wide range of interstimulus
intervals (ISIs) between TMS and PNS, plausibly due to an
increased number of interactions between pre- and post-synaptic
volleys (12). High-intensity TMS pulses (100% of maximum
stimulator output [MSO]) employed in the protocol generate
multiple descending volleys, and high-frequency trains of PNS
(50–100Hz) increase the number of antidromic volleys. The
method is superior to PNS in its ability to improve hand function
in tetraplegic individuals (16). Long-term PAS is suggested to
induce long-term potentiation (7) and to possibly contribute to
functional reorganization in the corticospinal tracts (9), which
augments motor input to the paralyzed muscles and leads to
increased muscle strength and corresponding limb function (12,
14, 17).
Several studies reported changes in the excitability of
corticospinal projections to the lower limb muscles by means of
PAS (18–21). Reports on long-standing functional recovery by
means of long-term PAS are sparse. Only one case study reported
regained plantarflexion and dorsiflexion of the ankles of both
legs in an individual with paraplegia after long-term PAS (14).
Thus, long-term PAS-induced functional outcomes essential for
walking improvement remain generally unexplored.
Muscle strength is strongly correlated to functional gait
outcomes (22, 23). Weakness in individual muscles modifies
walking and induces different variations of pathological gait
patterns (24). Walking alteration after SCI depends on weakness
in key muscles important for gait, their residual strength, and
the availability of muscles to compensate for this weakness.
Thus, long-term PAS may be an important therapeutic option
for specific targeting of the weakest muscles and for enhancing
their strength, thereby improving walking in a heterogenic SCI
population. Here, we investigated the effects of a long-term PAS
intervention of 8 weeks on leg muscle strength and walking
ability. Our primary goal was to assess whether long-term PAS
delivered 3–5 times per week to the nerves supplying the weakest
muscles for 20min per nerve can improve motor function as
measured by the Manual Motor Test.
MATERIALS AND METHODS
Participants
Five individuals (3 females, age range 48–70 years, mean age
60) with chronic incomplete tetraplegia of traumatic origin
(Table 1) were enrolled in the study. The study was registered at
clinicaltrials.gov (NCT03459885). Inclusion criteria were cervical
incomplete SCI of traumatic origin and age 18–70 years.
Exclusion criteria were contraindications for TMS or Magnetic
Resonance Imaging (MRI), including the presence of intracranial
metal objects, implanted electronics, epilepsy, pregnancy, high
intracranial pressure, and any brain pathology visible in
computer tomography or MRI (25). Initial leg muscle strength
and walking ability varied between participants (Table 1).
Conventional rehabilitation and medication of participants prior
to the study were not modified during the intervention or
the follow-up (Table 1). To ensure that any lack of vitamins
or minerals would not hinder the therapeutic effect, all
participants were asked to take a standard multivitamin dose
during intervention and follow-up. Participants provided written
informed consent prior to the study. The study was approved
by the Ethics Committee of the Hospital District of Helsinki
and Uusimaa.
Study Design
PAS was given for 2 months, 5 times per week during first 2
weeks (10 sessions) and 3 times per week during the subsequent
interventions (18 sessions, Figure 1). The duration of one PAS
session depended on the number of stimulated nerve-hotspot
pairs and lasted 80–120min (Table 2). Nerves supplying the weak
muscles with MMT scores of 0 to 3 (pre-PAS) were selected
for stimulation in each patient. This focused the treatment
on the weakest muscles and optimized duration of a single
PAS session. Thus, in participant 1, only the nerves of the
left leg were stimulated, in participants 2 to 4 both legs were
stimulated, and in participant 5 only the right leg was stimulated.
All stimulated nerves are shown in Table 2. The patients were
evaluated clinically immediately prior to the study (pre-PAS),
after 1 month of stimulation (mid-PAS), after 2 months of
stimulation (post-PAS), and after the 1-month follow-up. All
enrolled patients completed the study. No patients were lost to
follow-up and the data of all patients were analyzed.
Navigated Transcranial Magnetic
Stimulation (nTMS)
Biphasic TMS pulses were delivered to the motor cortex by
an Eximia magnetic stimulator (Nexstim Ltd., Finland) with
a figure-of-eight coil (outer diameter 70mm). The patient’s
structural T1-weighted MRI (obtained with a 3T Siemens
Verio scanner, Siemens Healthcare, Germany) was employed
in NBS System 4.3 to build an individual 3D head model.
Gyral anatomy was utilized to identify a TMS hotspot, a site
within the contralateral motor cortex where stimulation most
readily elicited MEPs from the muscle of interest. The hotspots
were defined for the (first and second choice, respectively)
abductor hallucis or soleus muscles (innervated by the tibial
nerve), tibialis anterior or extensor digitorum brevis muscles
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TABLE 1 | Patient characteristics.
Patient Age Neurological
level
AIS Time since injury
(years, months)
Conventional rehabilitation (min x
times per week)
Medication affecting
CNS (mg/day)
MMT score L/R and
walking before the study
1 60–65 C1 D 3 y, 2m None tizanidine (4–10) 30/38—ambulatory
2 55–60 C5 D 3 y, 0m physiotherapy (60 × 1), gym (60 × 2),
swimming pool (60 × 1), walking
training (60 × 1)
pregabalin (150),
tizanidine (12), baclofen
(50)
35/26—ambulatory
3 70–75 C1 D 2 y, 10m physiotherapy (60 × 2), gym (90 × 3),
swimming pool (60 × 2), standing
with weight support (60 × 7), assisted
cycling (60 × 7)
amitriptylline (25),
gabapentin (1500),
clonazepam (1),
baclofen (60)
18/14—non-ambulatory
4 45–50 C5 D 12 y, 2m physiotherapy (60 × 2), gym (60 × up
to 6), swimming pool (45 × 1), cycling
on adapted bicycle (120–180 × 2–3)
zopiclone (7.5),
baclofen (20)
26/8—ambulatory
5 60–65 C5 D 8 y, 8m physiotherapy (60 × 1), swimming
pool (45 × 1)
none 43/32—ambulatory
AIS, American Spinal Injury Association Impairment Scale; D, motor incomplete SCI with half or more of key muscle functions below the neurological level having a muscle grade ≥ 3;
CNS, central nervous system.
FIGURE 1 | Time course of intervention.
(peroneal nerve), vastus medialis or lateralis muscles (femoral
nerve), and gluteus maximus (gluteal nerve) using a built-in
Eximia EMG device and surface electrodes (Neuroline 720;
Ambu A/S, Baller- up, Denmark). If no MEPs were obtained
from the first-choice muscle, the second-choice muscle was
used. The stimulated hotspots in each participant corresponded
to stimulated nerves (Table 2); e.g., in participant 1, four
hotspots in the left hemisphere were identified corresponding
to muscles innervated by right tibial, peroneal, femoral, and
gluteal nerves. Resting motor thresholds (RMTs) were higher
than 100% of MSO; consequently, a weak voluntary muscle
preactivation was used to obtain MEPs. TMS with an intensity
of 100% of MSO was used to elicit reliable MEPs during motor
mapping, and the same TMS intensity was thereafter used for all
PAS sessions.
Peripheral Nerve Stimulation (PNS)
The Dantec Keypoint electroneuromyography device
(Natus Medical Inc., USA) and surface electrodes utilized
for MEP recordings were used to determine mean
latency, amplitude, and persistence of F-waves. For this
purpose, 10 responses to 0.2-ms pulses at supramaximal
intensity were recorded from the same muscles as in MEP
measurements in each subject. PNS intensity used for
PAS was defined for each participant individually as the
minimum intensity inducing F-responses to single 1-ms pulses
(14, 16).
During PAS, 100-Hz PNS trains (1-ms square pulses, 6 pulses
per train, train duration 100ms) (15) were delivered using the
Keypoint device and surface electrodes. For the gluteal nerve
stimulation, the electrode placement was determined by an
anatomical landmark centered at the ischial tuberosity (26).
To ensure appropriate gluteal nerve stimulation, a tape roll
(45 × 25mm) was attached on top of the electrodes and the
patient sat on it pressing the electrodes toward the nerve. For
the femoral nerve stimulation, crossing of the inguinal crease
and femoral artery, located along the course of the femoral
nerve, was selected for electrode placement (27). Constant
pressure was manually applied to the electrodes to ensure
femoral nerve activation. The tibial nerve was stimulated behind
the medial malleolus. The peroneal nerve was stimulated at
the ankle.
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Paired Associative Stimulation (PAS)
In all PAS sessions, TMS intensity was 100% of stimulator
output (SO) and PNS intensity was defined individually for each
peripheral nerve. The conduction times for lower motor neurons
and upper motor neurons were estimated individually for each
hotspot-nerve pair by measuring the minimum F latency and
average MEP latency. ISI between TMS and PNS were calculated
using the formula F-latency minus MEP latency (13) to coincide
with the induced neuronal volleys at the level of the lumbar spinal
cord. Thus, ISI was individually adjusted and varied between
participants, depending on their physiological measures and the
extent and location of the injury. A positive ISI indicates that
PNS precedes TMS; a negative ISI indicates that TMS precedes
PNS. For PAS, the participants were seated in a comfortable chair
(14, 16). One PAS session consisted of stimulations of 4 to 6
hotspot-nerve pairs delivered in a pseudo-random order (20min
or 240 TMS-PNS pairs, see Table 2 for stimulated nerves and
stimulation time per patient). The participants were instructed to
plantarflex the ankle and slightly flex the knee during tibial nerve
stimulation (10min per movement), dorsiflex the ankle during
peroneal nerve stimulation, slightly flex the hip and extend the
knee (10min per movement) during femoral nerve stimulation,
and slightly extend the hip (by pressing the whole leg down
in sitting position) and abduct the hip during gluteal nerve
stimulation (10min per movement).
All patients tolerated TMS well. All patients were offered
local skin anesthesia by EMLA ointment to reduce possible
uncomfortable sensations caused by PNS (12, 28). Three patients
chose to use this ointment (Table 2).
Clinical Evaluations
An experienced physiotherapist specialized in SCI assessed the
strength of gluteus maximus and medius, iliopsoas, quadriceps
femoris, tibialis anterior, tibialis posterior, peroneus, long toe
extensors, hamstrings, gastrocnemius, and hip adductors with
the Manual Muscle Test (MMT). Spasticity was assessed with the
Modified Ashworth Scale (MAS) from the hip (flexors, extensors,
adductors), knee (flexors, extensors), and ankle (plantar flexors)
muscles. Motor function was also evaluated with the standard
American Spinal Injuries Association Impairment Scale (AIS).
The physiotherapist did not participate in PAS and was blinded
to the rule of nerve selection. The physiotherapist also measured
gait function. For this purpose, the maximum distance that
patients were able to walk without a break and without assistance
of another person and the corresponding total time were
measured and used to calculatemeanwalking speed. This test was
selected to evaluate the functional outcome of PAS. MMT, AIS
examination, and walking test were performed at each evaluation.
A physician examined the patients’ sensory function with AIS.
The MAS, AIS examination of sensory function, and Spinal Cord
Independence Measure (SCIM) were performed at the beginning
of the intervention and at follow-up.
Statistical Analysis
The mean MMT score of all evaluated muscles in both legs and
the mean MMT scores of the muscles innervated by each of the
stimulated nerves (partial MMT) in both legs were calculated
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FIGURE 2 | Medians of MMT scores (left) and AIS motor scores (right) before the intervention (Pre-PAS), after 1 month (Mid-PAS), and after 2 months (Post-PAS) of
stimulations and in the 1-month follow-up. Asterisks show significant differences (n = 5, p < 0.05).
in each participant for each evaluation separately. The muscles
with a value of 5 before the intervention (corresponding to
full muscle strength) were excluded from the analysis as no
further improvement could be detected byMMT. The differences
between MMT scores obtained in Mid- and Pre-PAS (change
during the first month of intervention), Post- and Pre-PAS
(change during the entire intervention), and Follow-up and Pre-
PAS (change during the intervention and the follow-up) were
also calculated. The mean AIS motor scores in both legs were
computed in each participant for each evaluation separately,
excluding the muscles with a value of 5 before the intervention.
Differences between mean AIS scores were computed as for
calculations forMMT scores. Differences in walking speed in pre-
PAS and post-PAS and in pre-PAS and follow-up were computed.
Due to technical failure, the walking test was not performed
for patient 1 in mid-PAS and the results of the second walking
evaluation were not included in the group analysis. The sum of
points obtained with the MAS was calculated for each of the four
evaluations separately. The sum of AIS sensory scores and SCIM
was computed for the pre-PAS and the follow-up.
Statistical comparisons were performed in IBM SPSS Statistics
(IBM Corp, Armonk, NY, USA, Version 24.0.) using the
Friedman test and Wilcoxon signed-rank test where appropriate.
Results are reported as medians. In addition, mean and standard
error of the mean are shown in the tables and quartiles in
figures. Regression analysis was used to assess the extent to which
the total variation in the changes of walking speed (dependent
variable) in the follow-up can be explained by the MMT score
in the pre-PAS (independent variable). Three regressions were
computed separately for all MMT scores, MMT scores of key
muscles, and MMT scores of remaining muscles. Key muscles
included gluteus maximus and gluteus medius, knee flexors,
knee extensors, and ankle plantar flexors. This selection was
based on previous reports on their significance particularly for
walking speed improvement (22) and neuromotor strategies
used in human locomotion (23). The remaining muscles
included hip flexors, ankle dorsiflexors, long toe extensors,
and adductors. The relationship between MMT scores and
changes in walking speed were assessed with Spearman’s rank
correlation coefficients.
RESULTS
Total MMT scores were increased by the PAS from Md = 2.58–
3.58 [n= 5, χ2(3)= 10.563; p= 0.014, Friedman’s test]. Post-hoc
analysis with Wilcoxon signed-rank test revealed an increase of
total MMT scores in Mid-PAS (see Figure 2 and Table 3, n =
5, Md = 0.69, z = −2.023; p = 0.043), Post-PAS (n = 5, Md =
1.23, z = −2.023; p = 0.043), and follow-up (n = 5, Md = 1.15,
z = −2.023; p = 0.043) when compared with Pre-PAS. Partial
MMT scores were increased by the PAS from Md = 2.40–3.67
[n = 5, χ2(3) = 11.298, p = 0.01, Friedman’s test]. Post-hoc
analysis with Wilcoxon signed-rank test revealed an increase of
partial MMT scores in Mid-PAS (Table 3, n = 5, Md = 0.60, z =
−2.023, p= 0.043), Post-PAS (n= 5, Md= 1.10, z=−2.023, p=
0.043) and follow-up (n = 5, Md = 1.10, z = −2.023, p = 0.043)
when compared with Pre-PAS. Raw MMT scores are presented
in Supplementary Table 1.
The median AIS motor scores increased from 3.00 (pre-PAS)
to 4.33 (Follow-up) [n= 5, χ2(3)= 8,733; p= 0.033; Friedman’s
test]. Post-hoc analysis with Wilcoxon signed-rank test revealed
an increase of AIS motor scores in Post-PAS (see Figure 2 and
Table 4, n = 5, Md = 1.40, z = −2.023; p = 0.043) and in
follow-up (n = 5, Md = 1.40, z = −2.032; p = 0.042) when
compared with Pre-PAS. The differences between Mid-PAS vs.
Pre-PAS (n = 5, Md = 1.17, z = −1.841; p = 0.066) were not
statistically significant. Raw AIS motor scores are presented in
Supplementary Table 2.
Walking speed did not change at the group level across all
evaluations [Md = 0.31 m/s [Pre-PAS] and 0.35 m/s [Follow-
up], n = 4, χ2(2) = 3,500, p = 0.174; Friedman’s test].
Nevertheless, walking speed increased in the post-PAS in all
ambulatory participants (n = 5, p = 0.031, binomial test).
Walking speed increased post-PAS in participants 1, 2, 4, and
5 (Table 5, n = 4, Md = 0.10 m/s). Participant 3, who was
non-ambulatory before the intervention, could take several steps
with an Eva support walker but this result was not quantifiable.
Walking distance increased in 3 out of 4 ambulatory participants
(Table 5). Changes in walking speed were heterogenic in follow-
up. Participants 2 and 5 further improved their walking speed,
whereas participant 3 remained stable. Although the walking
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speed of participant 1 decreased slightly in the follow-up when
compared with post-PAS speed, the speed was still higher than
in the pre-PAS test (Table 5). Participant 4 (with the longest
post-trauma time) demonstrated a more pronounced decrease of
walking speed in the follow-up.
A significant regression equation was found for all MMT
scores [n = 5, F(1, 3) = 18.564, p = 0.024, r = 0,872, p = 0.054],
with an R2 of 0.861. The patients’ predicted walking speed was
equal to −0.187 + 0.005x (total MMT score) m/s. The adjusted
R2
adj
= 0.815 indicates that ∼81.5% of variance in changes of
walking speed can be explained by the initial total MMT score.
When MMT scores of key muscles were used for prediction of
changes in walking speed, a significant regression equation y =
−0.224 + 0.010x (MMT score of key muscles) was observed for
the key muscle MMT score [n = 5, F(1, 3) = 102,330, p = 0.002]
with an R2 of 0.972 (adjusted R2
adj
= 0.962). The MMT score
of key muscles in pre-PAS and changes of walking speed in the
follow-up were linearly related (Figure 3) and highly correlated
(r = 0.975, p = 0.005). Results of regression analysis with MMT
scores of the remaining muscles were not significant [Figure 3B,
n= 5, F(1, 3) = 6.608, p= 0.082, adjusted R
2
adj
= 0.584, r = 0.816,
p= 0.092].
No significant changes in spasticity as assessed with the MAS
were observed in the mid-PAS (n = 5, Md = 0.00 points), in the
post-PAS (n= 5, Md=−2.00), or in the follow-up (n= 5, Md=
3,00) when compared with the corresponding values obtained in
the pre-PAS [Supplementary Table 3, n = 5, χ2(3) = 3,065, p =
0.382; Friedman’s test].
Differences between AIS sensory scores obtained in
the pre-PAS and in the follow-up were non-significant
(Supplementary Table 4, n = 5, Light touch Md = 1.00, z
= −1.841, p = 0.066, Pin-prick Md = 0.00, z = −0.535, p =
0.593). SCIM scores collected in the pre-PAS and the follow-up
did not differ (Supplementary Table 5, n = 5, Md = 0.00, z
= −1.342, p = 0.180). Participants 4 and 5 improved their
SCIM score by 15 and 9 points, respectively, mostly in Mobility
subscales (items 10–17, Supplementary Table 6). The SCIM
scores of the other participants remained the same. Participant 5
reported that pain disappeared in the right ankle after the PAS.
Participants 1–4 did not have pain before or after treatment.
Participant 4 (with longest post-trauma time) reported slightly
increased spasticity in his right hand and in the left leg as well as
tiredness on week 2 of the intervention, which later disappeared.
In week 5 he reported pain in his lower back while standing
up or sitting down. The participant temporarily increased pain
medication and received treatment from a physiatrist. The
participant did not discontinue treatment. Other participants did
not report any adverse effects.
DISCUSSION
The current study provides the first evidence that long-term
PAS may increase leg muscle strength. We observed that long-
term PAS applied for 2 months increased the total lower limb
MMT score by ∼1 point in each muscle. This effect was stable
after a 1-month follow-up. The results of AIS motor score
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TABLE 4 | AIS motor scores.
Patient Average motor score Difference
Pre-PAS Mid-PAS Post-PAS Follow-up Mid-PAS—Pre-PAS Post-PAS—Pre-PAS Follow-up— Pre-PAS
1 3.40 4.80 4.80 4.80 1.40 1.40 1.40
2 3.33 4.50 4.00 4.33 1.17 0.67 1.00
3 2.50 3.67 3.83 4.00 1.17 1.33 1.50
4 1.60 3.60 3.40 2.60 2.00 1.80 1.00
5 3.00 3.00 5.00 4.60 0.00 2.00 1.60
Mean 2.77 3.91 4.21 4.07 1.15 1.44 1.30
SE 0.33 0.33 0.30 0.39 0.32 0.23 0.13
AIS, American Spinal Injury Association Impairment Scale.
TABLE 5 | Walking speed.
Distance (m)/Time (s) Speed (m/s) Difference
Patient Pre-PAS Post-PAS Follow-up Pre-PAS Post-PAS Follow-up Post-PAS—Pre-PAS Follow-up— Pre-PAS
1 80/266 86/197 172/435 0.30 0.44 0.40 0.14 0.09
2 43/205 430/1560 125/420 0.21 0.28 0.30 0.07 0.09
3 n/a n/a n/a n/a n/a n/a n/a n/a
4 38/117 27/60 38/144 0.32 0.45 0.26 0.13 −0.06
5 86/107 420/494 688/689 0.80 0.85 1.00 0.05 0.20
Median 61.50/161.00 253.00/345.50 148.50/427.50 0.31 0.45 0.35 0.10 0.09
Mean 61.75/173.75 240.75/577.75 255.75/422.00 0.41 0.50 0.49 0.09 0.08
SE 11.70/33.83 95.77/303.85 131.24/99.58 0.12 0.11 0.15 0.02 0.05
n/a, not available.
FIGURE 3 | Relationship between the sum of the MMT scores collected in stimulated lower limbs prior the intervention (Pre-PAS) from the key muscles (left) and
remaining muscles (right) and changes in walking speed obtained during follow-up. Linear regression—solid and dashed lines. R—only right leg was stimulated,
L—only left leg was stimulated, B—both legs were stimulated.
revealed a similar increase of muscle strength by ∼1 point per
muscle. Quantitatively similar findings were obtained in previous
studies (16, 29), where long-term PAS was applied for 1 month
and improved hand MMT scores by ∼1 point in a group of
individuals with chronic incomplete tetraplegia. Leg muscles are
considerably larger than hand muscles and thus more profound
changes than those in hand muscles are required to increase
the MMT score (which evaluates the capacity, e.g., to lift the
limb in different positions against gravity). Obtaining clinically
meaningful results also requires greater changes in the lower than
upper limbs. The similar increase of muscle strength observed in
the current study can be explained by a longer intervention than
that in our previous work that focused on upper limbs (16). The
magnitude and stability of the overall PAS therapeutic effect can
be positively related to the number of PAS sessions as observed
in previous studies (14, 16, 17). However, age, severity of injury,
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and residual muscle strength can affect long-term PAS outcomes.
Thus, it is important to consider these factors when planning
individualized treatment to maximize the clinical efficacy of PAS.
In the present study, PAS was applied in a heterogenous group
of participants. Initial lower limb muscle strength measured by
MMT score and AIS motor score varied between participants.
Stable improvements in lower limb muscle strength were
observed in all participants. This increases the external validity
of the present study. These results support efficacy of long-term
PAS and also demonstrate an increase of walking speed post-PAS.
Walking distance increased in 3 out of 4 ambulatory participants.
The design of the study, which investigated both lower limb
strength and locomotion, limited the possibility of stimulation
of only one limb in all participants for controlling the effects of
stimulation. However, in Participant 1, only the stimulated leg
improved (Supplementary Table 1).
All participants had a standard rehabilitation schedule before
the intervention and this schedule continued unchanged during
the intervention and the follow-up period. The average changes
of AIS motor scores during PAS ranged from 1.2 (in Mid-PAS) to
1.4 (in Post-PAS) points and were stable during follow-up. In SCI,
motor improvements occur within the first 6–9 months and a
plateau is usually reached by 12months post-injury withminimal
chance of further improvement (30). This excludes the possibility
of spontaneous changes in muscle strength at the chronic stage.
Improvements in muscle strength were also stable in follow-up
as shown by MMT and AIS scores. The observed effects were not
related to changes in spasticity or sensory function or caused by
changes in training ormedication; this is consistent with previous
studies (14, 16, 29).
We selected the nerves innervating the weakest muscles
for stimulation. This approach also led to improvements
in the muscles that were not directly innervated by the
stimulated nerves. Improvements in weak muscles plausibly
affected the entire limb by making walking easier and thus
promoting increased use of all muscles. Activation of the
neighboring regions of the motor cortex and peripheral nerves
is also plausible.
PAS was combined with a slight motor activation. Paired
corticospinal-motoneuronal stimulation combined with a small
level of isometric muscle contraction has been shown to
significantly improve corticospinal transmission in people with
SCI when compared with corresponding stimulation applied
at rest (31). It is plausible that motor activation lowers motor
thresholds centrally and peripherally; the number of orthodromic
TMS-induced volleys and therefore the number of interactions
between orthodromic and antidromic volleys might be increased.
Movements might also activate secondary motor areas, rewiring
them in synchrony with the stimulated corticospinal tract in a
beneficial manner. The patients were instructed to activate the
limbs during the stimulation only slightly; the amount of physical
training added by this intervention when compared to their
regular physiotherapy is small. Therefore, motor activation alone
cannot explain the therapeutic effect.
A previous study revealed that high-frequency repetitive
TMS applied immediately before robotic training sessions
improved motor function in a chronic SCI patient (32). The
authors hypothesized that rTMS increased M1 excitability and
recruited stunned or dysfunctional connections. Our approach
also incorporates both TMS and lower limb activation. However,
PAS protocols, including ours, use low-frequency TMS, which are
known to be inhibitory (33). This highlights the role of Hebbian
plasticity as the most probable mechanism of the observed PAS
effects (7, 8).
Correlation and significant linear relations between initial
MMT scores collected in pre-PAS and changes of walking speed
after PAS indicate that MMT scores have predictive value for
changes in walking speed after long-term PAS. Key muscles can
provide even better prediction. Changes in MMT scores in these
muscles were shown to predict changes in walking speed after
locomotor training (22). Regression analyses indicate that the
same amount of stimulation will produce different effects on
walking speed depending on the initial state of the leg muscles.
Information on this relationship is particularly important for
patient selection and estimation of treatment duration. Longer
treatment plausibly produces larger improvements, according
to the results of the previous PAS interventions (14, 16,
17). A previous study revealed the feasibility of achieving a
maximal MMT score and independent use of upper extremities
by means of long-term PAS (17). This opens new, attractive
prospects in recovering locomotor function in people with
chronic tetraplegia.
Age reduces neuroplasticity and the subsequent restoration
of motor function after SCI (1), independent of rehabilitation
strategy (22, 34). However, our results suggest that long-term PAS
appears to be a promising therapeutic approach in 48–70-year-
old subjects. Moreover, in this study we observed a stable increase
of muscle strength in a highly heterogenous SCI group, including
a non-ambulatory participant, individuals using a wheelchair,
and independently walking subjects.
In our previous studies on PAS therapeutic effects in the
upper limbs (14, 16, 17, 29), the ISI between TMS and PNS was
calculated to coincide with stimulation-induced volleys in the
cervical spinal cord, which is both the location of the stimulated
lower motor neuron cell bodies and the site of the injury. Here,
the stimuli were coinciding at the lumbar spinal cord, whereas
the injury was in the cervical spinal cord. This suggests that PAS
strengthens residual connectivity regardless of the location of
the injury.
The 80–120-min duration of one PAS session depended on
the number of stimulated nerves. The protocol was generally
well-tolerated by the patients. Considering the variability of
available resources in different countries, further research is
needed to evaluate whether PAS protocols that employ higher
TMS frequency with shorter duration (35, 36) could increase
clinical feasibility.
A limitation of this study was the small sample size; the results
of this case series should be considered exploratory. The observed
motor changes and functional outcomes following long-term
application of PAS in lower limbs enhance our understanding
of the therapeutic mechanism of PAS and contribute to further
development of long-term PAS therapy. The results of this proof-
of-concept pilot study indicate a possible beneficial effect of
long-term PAS in the rehabilitation of traumatic tetraplegia.
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